| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.685 | 0.015 | 0.685 | Analgesic | 0.368 0.099 CID_154699838 | ||
| 0.664 | 0.005 | 0.664 | Psychostimulant | 0.658 0.005 CID_154699838 | ||
| 0.554 | 0.025 | 0.554 | Aldehyde oxidase inhibitor | |||
| 0.532 | 0.017 | 0.532 | Calcium channel L-type activator | 0.375 0.099 CID_154699838 | ||
| 0.519 | 0.013 | 0.749 | Vasodilator, coronary | 0.749 0.004 CID_154699838 | CID_154699838 | |
| 0.535 | 0.039 | 0.795 | Transcription factor NF kappa B inhibitor | 0.795 0.013 CID_154699838 | CID_154699838 | |
| 0.492 | 0.004 | 0.492 | 5 Hydroxytryptamine uptake inhibitor | 0.109 0.024 CID_154699838 | ||
| 0.445 | 0.015 | 0.445 | Peroxidase inhibitor | |||
| 0.439 | 0.025 | 0.439 | Interleukin antagonist | 0.253 0.06 CID_154699838 | ||
| 0.436 | 0.023 | 0.529 | Antiamyloidogenic | 0.529 0.014 CID_154699838 | CID_154699838 | |
| 0.38 | 0.005 | 0.38 | NMDA receptor antagonist | |||
| 0.448 | 0.084 | 0.448 | Caspase 9 stimulant | 0.406 0.107 CID_154699838 | ||
| 0.423 | 0.064 | 0.49 | 5 Hydroxytryptamine release inhibitor | 0.49 0.036 CID_154699838 | CID_154699838 | |
| 0.371 | 0.012 | 0.371 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.386 | 0.03 | 0.669 | Hypoglycemic | 0.669 0.005 CID_154699838 | CID_154699838 | |
| 0.376 | 0.023 | 0.532 | Interleukin agonist | 0.532 0.007 CID_154699838 | CID_154699838 | |
| 0.419 | 0.066 | 0.504 | Histamine release inhibitor | 0.504 0.027 CID_154699838 | CID_154699838 | |
| 0.36 | 0.011 | 0.446 | Peptidyltransferase inhibitor | 0.446 0.005 CID_154699838 | CID_154699838 | |
| 0.387 | 0.048 | 0.387 | 5 Hydroxytryptamine release stimulant | 0.197 0.124 CID_154699838 | ||
| 0.368 | 0.038 | 0.465 | Interleukin 2 agonist | 0.465 0.013 CID_154699838 | CID_154699838 | |
| 0.359 | 0.035 | 0.359 | Superoxide dismutase inhibitor | |||
| 0.332 | 0.015 | 0.332 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.404 | 0.089 | 0.771 | Cyclophilin D inhibitor | 0.771 0.008 CID_154699838 | CID_154699838 | |
| 0.313 | 0.004 | 0.313 | Inducible nitric-oxide synthase inhibitor | 0.075 0.071 CID_154699838 | ||
| 0.355 | 0.046 | 0.355 | Calcium channel activator | |||
| 0.31 | 0.004 | 0.31 | Adrenaline uptake inhibitor | 0.118 0.014 CID_154699838 | ||
| 0.35 | 0.051 | 0.35 | Lipoxygenase inhibitor | |||
| 0.307 | 0.022 | 0.307 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.213 0.062 CID_154699838 | ||
| 0.306 | 0.021 | 0.473 | Melanin inhibitor | 0.473 0.008 CID_154699838 | CID_154699838 | |
| 0.318 | 0.037 | 0.318 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.28 | 0.004 | 0.28 | Toll-Like receptor 3 antagonist | 0.125 0.026 CID_154699838 | ||
| 0.341 | 0.068 | 0.61 | Cholesterol antagonist | 0.61 0.017 CID_154699838 | CID_154699838 | |
| 0.266 | 0.005 | 0.266 | Nitric-oxide synthase inhibitor | |||
| 0.259 | 0.005 | 0.259 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.314 | 0.065 | 0.392 | Spasmolytic | 0.392 0.042 CID_154699838 | CID_154699838 | |
| 0.27 | 0.025 | 0.27 | Insulin sensitizer | 0.255 0.032 CID_154699838 | ||
| 0.256 | 0.025 | 0.418 | Protein kinase stimulant | 0.418 0.007 CID_154699838 | CID_154699838 | |
| 0.328 | 0.098 | 0.328 | GABA C receptor rho-3 antagonist | |||
| 0.282 | 0.055 | 0.383 | Vasodilator | 0.383 0.026 CID_154699838 | CID_154699838 | |
| 0.229 | 0.005 | 0.229 | Adenylate cyclase stimulant | 0.161 0.046 CID_154699838 | ||
| 0.226 | 0.005 | 0.226 | Glutamate decarboxylase inhibitor | |||
| 0.255 | 0.036 | 0.257 | Neurotrophic factor enhancer | 0.257 0.035 CID_154699838 | CID_154699838 | |
| 0.251 | 0.032 | 0.251 | Nitric-oxide synthase stimulant | 0.245 0.036 CID_154699838 | ||
| 0.221 | 0.005 | 0.221 | Adrenaline agonist | |||
| 0.232 | 0.024 | 0.232 | Anesthetic local | |||
| 0.25 | 0.043 | 0.25 | Growth hormone agonist | |||
| 0.211 | 0.007 | 0.211 | Protein kinase B gamma inhibitor | |||
| 0.234 | 0.03 | 0.234 | Antipruritic | 0.146 0.098 CID_154699838 | ||
| 0.291 | 0.088 | 0.291 | Sodium/bile acid cotransporter inhibitor | 0.219 0.163 CID_154699838 | ||
| 0.231 | 0.031 | 0.231 | Acetylcholine M1 receptor antagonist | |||
| 0.229 | 0.03 | 0.229 | Phospholipase C inhibitor | 0.184 0.057 CID_154699838 | ||
| 0.215 | 0.016 | 0.215 | Carbonic anhydrase XV inhibitor | |||
| 0.272 | 0.073 | 0.556 | Antioxidant | 0.556 0.015 CID_154699838 | CID_154699838 | |
| 0.204 | 0.019 | 0.204 | Interleukin 1b antagonist | 0.162 0.033 CID_154699838 | ||
| 0.298 | 0.117 | 0.371 | Antiobesity | 0.371 0.078 CID_154699838 | CID_154699838 | |
| 0.201 | 0.02 | 0.201 | GABA C receptor agonist | |||
| 0.194 | 0.015 | 0.194 | Mucolytic | 0.193 0.015 CID_154699838 | ||
| 0.207 | 0.03 | 0.207 | Interleukin 1 antagonist | 0.13 0.075 CID_154699838 | ||
| 0.182 | 0.004 | 0.182 | Beta adrenoreceptor antagonist | |||
| 0.215 | 0.039 | 0.465 | Amylase inhibitor | 0.465 0.007 CID_154699838 | CID_154699838 | |
| 0.189 | 0.018 | 0.189 | Carbonic anhydrase III inhibitor | 0.104 0.057 CID_154699838 | ||
| 0.262 | 0.092 | 0.531 | Immunostimulant | 0.531 0.025 CID_154699838 | CID_154699838 | |
| 0.192 | 0.022 | 0.495 | Expectorant | 0.495 0.004 CID_154699838 | CID_154699838 | |
| 0.278 | 0.109 | 0.278 | Vasodilator, peripheral | 0.231 0.143 CID_154699838 | ||
| 0.239 | 0.073 | 0.495 | Free radical scavenger | 0.495 0.017 CID_154699838 | CID_154699838 | |
| 0.19 | 0.025 | 0.19 | Farnesoid X receptor antagonist | |||
| 0.227 | 0.066 | 0.227 | Anticonvulsant | |||
| 0.185 | 0.025 | 0.484 | Cyclooxygenase 3 inhibitor | 0.484 0.003 CID_154699838 | CID_154699838 | |
| 0.186 | 0.03 | 0.186 | Toll-Like receptor 2 antagonist | |||
| 0.183 | 0.029 | 0.183 | Adenylate cyclase inhibitor | 0.11 0.076 CID_154699838 | ||
| 0.181 | 0.028 | 0.181 | Alpha 2b adrenoreceptor antagonist | |||
| 0.219 | 0.068 | 0.219 | Amyloid beta aggregation inhibitor | 0.157 0.103 CID_154699838 | ||
| 0.195 | 0.045 | 0.195 | Phospholipase A2 inhibitor | 0.163 0.063 CID_154699838 | ||
| 0.173 | 0.026 | 0.173 | Nav1.4 sodium channel blocker | |||
| 0.177 | 0.03 | 0.177 | 5-Lipoxygenase inhibitor | |||
| 0.262 | 0.117 | 0.668 | Antithrombotic | 0.668 0.01 CID_154699838 | CID_154699838 | |
| 0.162 | 0.018 | 0.162 | Urease inhibitor | |||
| 0.149 | 0.004 | 0.149 | GABA B receptor agonist | |||
| 0.151 | 0.008 | 0.151 | Glycine transporter 2 inhibitor | |||
| 0.188 | 0.045 | 0.188 | Death-associated protein kinase 2 inhibitor | |||
| 0.163 | 0.024 | 0.163 | GABA C receptor antagonist | |||
| 0.143 | 0.005 | 0.143 | Beta 2 adrenoreceptor antagonist | |||
| 0.222 | 0.083 | 0.658 | Angiogenesis stimulant | 0.658 0.005 CID_154699838 | CID_154699838 | |
| 0.143 | 0.005 | 0.143 | Beta 1 adrenoreceptor antagonist | |||
| 0.162 | 0.024 | 0.162 | TRPA1 agonist | 0.104 0.081 CID_154699838 | ||
| 0.164 | 0.027 | 0.164 | Vanilloid 1 agonist | 0.15 0.039 CID_154699838 | ||
| 0.206 | 0.071 | 0.206 | Anesthetic general | 0.179 0.087 CID_154699838 | ||
| 0.165 | 0.032 | 0.165 | Antiadrenergic | |||
| 0.171 | 0.038 | 0.171 | Glutamate receptor antagonist | |||
| 0.161 | 0.032 | 0.161 | Adrenaline antagonist | |||
| 0.133 | 0.008 | 0.133 | NMDA receptor subunit 3B antagonist | |||
| 0.169 | 0.044 | 0.169 | NADPH oxidase inhibitor | 0.132 0.069 CID_154699838 | ||
| 0.144 | 0.022 | 0.144 | Anabolic | |||
| 0.14 | 0.018 | 0.14 | Alpha adrenoreceptor agonist | |||
| 0.164 | 0.042 | 0.349 | Monophenol monooxygenase inhibitor | 0.349 0.014 CID_154699838 | CID_154699838 | |
| 0.146 | 0.025 | 0.146 | Creatine kinase inhibitor | |||
| 0.137 | 0.017 | 0.137 | Somatostatin 1 agonist | 0.076 0.056 CID_154699838 | ||
| 0.22 | 0.1 | 0.241 | DNA damaging | 0.241 0.085 CID_154699838 | CID_154699838 | |
| 0.121 | 0.005 | 0.139 | Factor IXa inhibitor | 0.139 0.004 CID_154699838 | CID_154699838 | |
| 0.143 | 0.028 | 0.143 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.152 | 0.038 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.144 0.058 CID_154699838 | ||
| 0.271 | 0.158 | 0.629 | Antibacterial | 0.629 0.015 CID_154699838 | CID_154699838 | |
| 0.185 | 0.075 | 0.185 | P-glycoprotein inhibitor | 0.183 0.077 CID_154699838 | ||
| 0.138 | 0.028 | 0.138 | Prolactin inhibitor | |||
| 0.122 | 0.015 | 0.122 | GABA aminotransferase inhibitor | 0.118 0.017 CID_154699838 | ||
| 0.129 | 0.023 | 0.129 | Histidine decarboxylase inhibitor | |||
| 0.141 | 0.037 | 0.141 | Alpha 2c adrenoreceptor antagonist | |||
| 0.16 | 0.056 | 0.333 | Cell wall synthesis inhibitor | 0.333 0.008 CID_154699838 | CID_154699838 | |
| 0.108 | 0.005 | 0.108 | Glycine transporter 1 inhibitor | |||
| 0.116 | 0.014 | 0.116 | Glycine receptor agonist | 0.094 0.025 CID_154699838 | ||
| 0.107 | 0.008 | 0.107 | NMDA receptor subunit 3A antagonist | |||
| 0.123 | 0.024 | 0.123 | Ornithine decarboxylase inhibitor | 0.099 0.046 CID_154699838 | ||
| 0.141 | 0.042 | 0.141 | Aminopeptidase B inhibitor | |||
| 0.223 | 0.125 | 0.223 | Insulysin inhibitor | |||
| 0.196 | 0.098 | 0.327 | Hypolipemic | 0.327 0.041 CID_154699838 | CID_154699838 | |
| 0.166 | 0.069 | 0.166 | Neurotensin receptor agonist | |||
| 0.146 | 0.05 | 0.146 | Aldehyde dehydrogenase inhibitor | 0.125 0.066 CID_154699838 | ||
| 0.158 | 0.063 | 0.269 | Lipid peroxidase inhibitor | 0.269 0.024 CID_154699838 | CID_154699838 | |
| 0.172 | 0.077 | 0.172 | Succinate dehydrogenase inhibitor | |||
| 0.11 | 0.016 | 0.11 | Alcohol oxidase inhibitor | |||
| 0.122 | 0.029 | 0.122 | Aminoacyl-tRNA synthetase inhibitor | 0.096 0.049 CID_154699838 | ||
| 0.109 | 0.016 | 0.109 | Estrogen-related receptor beta agonist | |||
| 0.133 | 0.04 | 0.133 | Transcription factor STAT6 inhibitor | |||
| 0.221 | 0.128 | 0.242 | Hypoxia-inducible factor 1 alpha inhibitor | 0.242 0.108 CID_154699838 | CID_154699838 | |
| 0.212 | 0.121 | 0.212 | Transcription factor STAT inhibitor | |||
| 0.12 | 0.029 | 0.12 | Carbonic anhydrase VI inhibitor | |||
| 0.126 | 0.035 | 0.126 | GABA C receptor rho-1 antagonist | |||
| 0.203 | 0.114 | 0.203 | Neuropeptide Y2 antagonist | |||
| 0.14 | 0.052 | 0.264 | Alkylator | 0.264 0.015 CID_154699838 | CID_154699838 | |
| 0.128 | 0.041 | 0.128 | Estrogen antagonist | |||
| 0.118 | 0.033 | 0.118 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.115 | 0.03 | 0.115 | Porphobilinogen synthase inhibitor | |||
| 0.112 | 0.028 | 0.112 | Bile acid receptor antagonist | |||
| 0.133 | 0.049 | 0.133 | Cystathionine beta-synthase inhibitor | 0.106 0.07 CID_154699838 | ||
| 0.144 | 0.061 | 0.149 | Heat shock protein 70 antagonist | 0.149 0.047 CID_154699838 | CID_154699838 | |
| 0.136 | 0.053 | 0.136 | Acetylcholine muscarinic antagonist | |||
| 0.086 | 0.005 | 0.086 | Dopamine D5 agonist | |||
| 0.086 | 0.006 | 0.086 | Beta 2 adrenoreceptor agonist | |||
| 0.12 | 0.044 | 0.12 | Bronchodilator | |||
| 0.104 | 0.029 | 0.104 | Vanilloid agonist | 0.079 0.074 CID_154699838 | ||
| 0.114 | 0.04 | 0.114 | Estrogen receptor beta antagonist | |||
| 0.093 | 0.021 | 0.093 | Dopamine uptake inhibitor | |||
| 0.111 | 0.04 | 0.111 | Opioid antagonist | |||
| 0.124 | 0.053 | 0.177 | Photosensitizer | 0.177 0.019 CID_154699838 | CID_154699838 | |
| 0.105 | 0.035 | 0.112 | Glutamate release inhibitor | 0.112 0.029 CID_154699838 | CID_154699838 | |
| 0.1 | 0.032 | 0.12 | Na+ K+ transporting ATPase inhibitor | 0.12 0.016 CID_154699838 | CID_154699838 | |
| 0.134 | 0.066 | 0.134 | Interleukin 4 antagonist | 0.131 0.071 CID_154699838 | ||
| 0.1 | 0.032 | 0.1 | NMDA 2 receptor antagonist | |||
| 0.2 | 0.134 | 0.2 | Transcription factor STAT3 inhibitor | |||
| 0.147 | 0.081 | 0.147 | CF transmembrane conductance regulator agonist | |||
| 0.085 | 0.02 | 0.085 | Beta 3 adrenoreceptor antagonist | |||
| 0.115 | 0.051 | 0.115 | DOPA decarboxylase inhibitor | |||
| 0.128 | 0.065 | 0.128 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.085 | 0.024 | 0.085 | Acetylcholine M3 receptor antagonist | |||
| 0.109 | 0.05 | 0.109 | Sphingomyelinase inhibitor | 0.093 0.068 CID_154699838 | ||
| 0.114 | 0.055 | 0.114 | Electron transport complex I inhibitor | |||
| 0.093 | 0.034 | 0.093 | Glutamate dehydrogenase inhibitor | 0.068 0.06 CID_154699838 | ||
| 0.093 | 0.035 | 0.093 | Keratolytic | |||
| 0.081 | 0.023 | 0.081 | Alpha 2 adrenoreceptor agonist | |||
| 0.13 | 0.073 | 0.13 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.15 | 0.094 | 0.354 | Nitric oxide antagonist | 0.354 0.031 CID_154699838 | CID_154699838 | |
| 0.139 | 0.083 | 0.449 | Hemostatic | 0.449 0.005 CID_154699838 | CID_154699838 | |
| 0.126 | 0.072 | 0.126 | Antibacterial (Helicobacter pylori) | |||
| 0.087 | 0.034 | 0.087 | Opioid delta receptor antagonist | |||
| 0.079 | 0.026 | 0.079 | NMDA 2C receptor antagonist | |||
| 0.141 | 0.091 | 0.249 | Interferon gamma antagonist | 0.249 0.029 CID_154699838 | CID_154699838 | |
| 0.07 | 0.02 | 0.07 | Dopamine transporter inhibitor | |||
| 0.086 | 0.037 | 0.086 | Opioid mu receptor antagonist | |||
| 0.078 | 0.029 | 0.078 | 5 Hydroxytryptamine 2A agonist | |||
| 0.091 | 0.043 | 0.094 | Carbonic anhydrase XIII inhibitor | 0.094 0.041 CID_154699838 | CID_154699838 | |
| 0.09 | 0.042 | 0.09 | Macrophage migration inhibitory factor inhibitor | |||
| 0.124 | 0.076 | 0.124 | Cyclooxygenase 1 inhibitor | |||
| 0.109 | 0.062 | 0.109 | Ferrochelatase inhibitor | |||
| 0.091 | 0.045 | 0.091 | Opioid kappa receptor antagonist | |||
| 0.083 | 0.037 | 0.083 | MAP kinase kinase 7 inhibitor | |||
| 0.049 | 0.004 | 0.049 | Alpha 2a adrenoreceptor agonist | |||
| 0.087 | 0.042 | 0.113 | Interferon agonist | 0.113 0.02 CID_154699838 | CID_154699838 | |
| 0.073 | 0.029 | 0.073 | Carbonic anhydrase stimulant | |||
| 0.054 | 0.012 | 0.054 | Beta adrenoreceptor agonist | |||
| 0.057 | 0.015 | 0.057 | Kinesin-like protein 1 inhibitor | |||
| 0.057 | 0.015 | 0.057 | Kinesin antagonist | |||
| 0.071 | 0.03 | 0.071 | Acetylcholine M5 receptor antagonist | |||
| 0.085 | 0.045 | 0.085 | Alpha 2a adrenoreceptor antagonist | |||
| 0.054 | 0.014 | 0.054 | Alpha 1d adrenoreceptor agonist | |||
| 0.065 | 0.026 | 0.065 | Urokinase inhibitor | |||
| 0.093 | 0.053 | 0.093 | Alpha 2 adrenoreceptor antagonist | |||
| 0.116 | 0.078 | 0.116 | Cholinergic antagonist | |||
| 0.056 | 0.018 | 0.075 | Cytokine production stimulant | 0.075 0.005 CID_154699838 | CID_154699838 | |
| 0.071 | 0.033 | 0.092 | Interferon inducer | 0.092 0.016 CID_154699838 | CID_154699838 | |
| 0.041 | 0.004 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.04 0.004 CID_154699838 | ||
| 0.051 | 0.014 | 0.051 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.064 | 0.027 | 0.064 | NMDA 2A receptor antagonist | |||
| 0.086 | 0.049 | 0.086 | Acetylcholine nicotinic antagonist | |||
| 0.133 | 0.096 | 0.318 | Thrombolytic | 0.318 0.021 CID_154699838 | CID_154699838 | |
| 0.113 | 0.077 | 0.113 | Acetylcholine antagonist | |||
| 0.056 | 0.02 | 0.056 | Dopamine beta hydroxylase inhibitor | |||
| 0.082 | 0.046 | 0.082 | CYP2A6 inhibitor | |||
| 0.114 | 0.078 | 0.114 | MAO inhibitor | |||
| 0.048 | 0.016 | 0.048 | Diamine oxidase inhibitor | |||
| 0.05 | 0.02 | 0.05 | Somatostatin 1 antagonist | |||
| 0.089 | 0.06 | 0.174 | Triose-phosphate isomerase inhibitor | 0.174 0.014 CID_154699838 | CID_154699838 | |
| 0.059 | 0.029 | 0.081 | Leukotriene B4 antagonist | 0.081 0.015 CID_154699838 | CID_154699838 | |
| 0.07 | 0.041 | 0.07 | Glucagon-like peptide 1 agonist | |||
| 0.085 | 0.057 | 0.085 | Myeloperoxidase inhibitor | |||
| 0.061 | 0.034 | 0.061 | Maillard reaction inhibitor | |||
| 0.043 | 0.016 | 0.043 | Somatostatin 5 antagonist | |||
| 0.115 | 0.089 | 0.115 | Nav1.2 sodium channel blocker | |||
| 0.054 | 0.028 | 0.054 | Glycine transporter inhibitor | |||
| 0.202 | 0.177 | 0.396 | Apoptosis antagonist | 0.396 0.04 CID_154699838 | CID_154699838 | |
| 0.074 | 0.049 | 0.074 | Aminopeptidase I inhibitor | |||
| 0.082 | 0.059 | 0.082 | Protein kinase A inhibitor | |||
| 0.104 | 0.082 | 0.104 | Cholesterol synthesis inhibitor | |||
| 0.047 | 0.026 | 0.047 | Parathyroid hormone antagonist | |||
| 0.072 | 0.051 | 0.072 | Cathepsin G inhibitor | |||
| 0.167 | 0.147 | 0.167 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.031 | 0.011 | 0.031 | Thyroid hormone agonist | |||
| 0.035 | 0.016 | 0.035 | Glutamate (mGluR3) agonist | |||
| 0.115 | 0.095 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.058 | 0.039 | 0.058 | Alpha 1 adrenoreceptor agonist | |||
| 0.046 | 0.027 | 0.046 | Oxytocin agonist | |||
| 0.095 | 0.076 | 0.095 | Adenylate kinase inhibitor | |||
| 0.044 | 0.027 | 0.044 | Growth hormone release inhibitor | |||
| 0.17 | 0.152 | 0.17 | RNA-directed DNA polymerase inhibitor | |||
| 0.081 | 0.064 | 0.081 | Androgen antagonist | |||
| 0.025 | 0.008 | 0.025 | Factor IX inhibitor | |||
| 0.031 | 0.014 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.037 | 0.021 | 0.037 | Somatostatin 5 agonist | |||
| 0.043 | 0.026 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.037 | 0.022 | 0.037 | Phosphoglycerate kinase inhibitor | |||
| 0.065 | 0.049 | 0.065 | Neuronal nicotinic receptor antagonist | |||
| 0.133 | 0.119 | 0.204 | Interleukin 6 antagonist | 0.204 0.038 CID_154699838 | CID_154699838 | |
| 0.138 | 0.124 | 0.383 | Hepatoprotectant | 0.383 0.015 CID_154699838 | CID_154699838 | |
| 0.053 | 0.039 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.025 | 0.012 | 0.025 | Beta 1 adrenoreceptor agonist | |||
| 0.109 | 0.096 | 0.109 | Bone formation stimulant | |||
| 0.065 | 0.052 | 0.065 | Glutamate (mGluR6) antagonist | |||
| 0.053 | 0.041 | 0.053 | Carbonic anhydrase VB inhibitor | |||
| 0.093 | 0.082 | 0.159 | Toll-Like receptor 4 antagonist | 0.159 0.017 CID_154699838 | CID_154699838 | |
| 0.021 | 0.009 | 0.021 | Alpha 2b adrenoreceptor agonist | |||
| 0.079 | 0.068 | 0.079 | Histamine N-methyltransferase inhibitor | |||
| 0.073 | 0.062 | 0.073 | Estrogen receptor alpha antagonist | |||
| 0.095 | 0.086 | 0.095 | Protein kinase C gamma inhibitor | |||
| 0.096 | 0.088 | 0.096 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.082 | 0.074 | 0.082 | MAO B inhibitor | |||
| 0.025 | 0.018 | 0.041 | Vanilloid 2 agonist | 0.041 0.004 CID_154699838 | CID_154699838 | |
| 0.081 | 0.073 | 0.131 | NADH dehydrogenase inhibitor | 0.131 0.023 CID_154699838 | CID_154699838 | |
| 0.06 | 0.053 | 0.06 | Transcription factor RelA inhibitor | |||
| 0.089 | 0.082 | 0.192 | Mediator release inhibitor | 0.192 0.016 CID_154699838 | CID_154699838 | |
| 0.09 | 0.083 | 0.09 | Glutamate (mGluR7) agonist | |||
| 0.097 | 0.09 | 0.097 | Nav1.5 sodium channel blocker | |||
| 0.047 | 0.04 | 0.047 | Squalene epoxidase inhibitor | |||
| 0.05 | 0.043 | 0.05 | Vanilloid 2 antagonist | |||
| 0.083 | 0.076 | 0.083 | Polo-like kinase-1 inhibitor | |||
| 0.051 | 0.045 | 0.051 | Sphingosine kinase 2 inhibitor | |||
| 0.022 | 0.015 | 0.024 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 CID_154699838 | CID_154699838 | |
| 0.05 | 0.044 | 0.05 | NMDA 2B receptor antagonist | |||
| 0.079 | 0.073 | 0.146 | Transcription factor NF kappa B stimulant | 0.146 0.017 CID_154699838 | CID_154699838 | |
| 0.022 | 0.017 | 0.028 | Dopamine D1 agonist | 0.028 0.01 CID_154699838 | CID_154699838 | |
| 0.087 | 0.082 | 0.087 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.027 | 0.022 | 0.027 | Purinergic P2Y15 antagonist | |||
| 0.042 | 0.037 | 0.107 | Mannosidase inhibitor | 0.107 0.005 CID_154699838 | CID_154699838 | |
| 0.018 | 0.014 | 0.018 | Estrogen-related receptor gamma agonist | |||
| 0.019 | 0.014 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 CID_154699838 | CID_154699838 | |
| 0.034 | 0.029 | 0.076 | Antibiotic Aminoglycoside-like | 0.076 0.005 CID_154699838 | CID_154699838 | |
| 0.112 | 0.108 | 0.112 | Nav1.6 sodium channel blocker | |||
| 0.124 | 0.12 | 0.124 | Arachidonic acid antagonist | |||
| 0.056 | 0.053 | 0.056 | Ryanodine receptor antagonist | |||
| 0.049 | 0.046 | 0.094 | Alpha-mannosidase inhibitor | 0.094 0.007 CID_154699838 | CID_154699838 | |
| 0.069 | 0.067 | 0.069 | Potassium channel (Tandem pore domain) blocker | |||
| 0.072 | 0.07 | 0.072 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.034 | 0.031 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.2 | 0.198 | 0.464 | Immunosuppressant | 0.464 0.043 CID_154699838 | CID_154699838 | |
| 0.094 | 0.092 | 0.127 | DNA polymerase I inhibitor | 0.127 0.063 CID_154699838 | CID_154699838 | |
| 0.019 | 0.017 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.137 | 0.136 | 0.137 | Antimitotic | |||
| 0.029 | 0.027 | 0.029 | Estrogen receptor alpha agonist | |||
| 0.066 | 0.065 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.057 | 0.056 | 0.057 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.038 | 0.037 | 0.048 | Guanylate cyclase inhibitor | 0.048 0.023 CID_154699838 | CID_154699838 | |
| 0.096 | 0.098 | 0.121 | Microtubule formation inhibitor | 0.121 0.06 CID_154699838 | CID_154699838 | |
| 0.168 | 0.171 | 0.293 | DNA synthesis inhibitor | 0.293 0.046 CID_154699838 | CID_154699838 | |
| 0.076 | 0.084 | 0.08 | Interleukin 5 antagonist | 0.08 0.073 CID_154699838 | CID_154699838 | |
| 0.056 | 0.064 | 0.088 | Neuraminidase (influenza) inhibitor | 0.088 0.021 CID_154699838 | CID_154699838 | |
| 0.02 | 0.029 | 0.03 | Uridine phosphorylase inhibitor | 0.03 0.018 CID_154699838 | CID_154699838 | |
| 0.076 | 0.09 | 0.12 | ATPase (Vacuolar H+) inhibitor | 0.12 0.02 CID_154699838 | CID_154699838 | |
| 0.049 | 0.063 | 0.065 | Adenine nucleotide translocase inhibitor | 0.065 0.02 CID_154699838 | CID_154699838 | |
| 0.036 | 0.054 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 CID_154699838 | CID_154699838 | |
| 0.05 | 0.069 | 0.113 | Phosphofructokinase-1 inhibitor | 0.113 0.027 CID_154699838 | CID_154699838 | |
| 0.223 | 0.245 | 0.485 | Apoptosis agonist | 0.485 0.079 CID_154699838 | CID_154699838 | |
| 0.044 | 0.066 | 0.082 | Neuraminidase inhibitor | 0.082 0.024 CID_154699838 | CID_154699838 | |
| 0.009 | 0.031 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.007 CID_154699838 | CID_154699838 | |
| 0.016 | 0.04 | 0.053 | Protein 30S ribosomal subunit inhibitor | 0.053 0.008 CID_154699838 | CID_154699838 | |
| 0.077 | 0.102 | 0.125 | Xanthine oxidase inhibitor | 0.125 0.045 CID_154699838 | CID_154699838 | |
| 0.033 | 0.063 | 0.05 | Carbonic anhydrase XIV inhibitor | 0.05 0.032 CID_154699838 | CID_154699838 | |
| 0.041 | 0.073 | 0.342 | Selectin antagonist | 0.342 0.004 CID_154699838 | CID_154699838 | |
| 0.017 | 0.05 | 0.053 | Arginase inhibitor | 0.053 0.013 CID_154699838 | CID_154699838 | |
| 0.088 | 0.121 | 0.158 | Alpha-N-acetylglucosaminidase inhibitor | 0.158 0.05 CID_154699838 | CID_154699838 | |
| 0.124 | 0.158 | 0.233 | ATPase inhibitor | 0.233 0.019 CID_154699838 | CID_154699838 | |
| 0.07 | 0.111 | 0.14 | UDP-glucose 4-epimerase inhibitor | 0.14 0.033 CID_154699838 | CID_154699838 | |
| 0.173 | 0.217 | 0.232 | Caspase 3 stimulant | 0.232 0.129 CID_154699838 | CID_154699838 | |
| 0.039 | 0.083 | 0.051 | Factor III inhibitor | 0.051 0.032 CID_154699838 | CID_154699838 | |
| 0.033 | 0.082 | 0.046 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 CID_154699838 | CID_154699838 | |
| 0.014 | 0.063 | 0.061 | Sodium/glucose cotransporter 2 inhibitor | 0.061 0.005 CID_154699838 | CID_154699838 | |
| 0.043 | 0.093 | 0.168 | Antineoplastic antibiotic | 0.168 0.027 CID_154699838 | CID_154699838 | |
| 0.066 | 0.118 | 0.111 | Uric acid excretion stimulant | 0.111 0.044 CID_154699838 | CID_154699838 | |
| 0.108 | 0.161 | 0.364 | Platelet adhesion inhibitor | 0.364 0.017 CID_154699838 | CID_154699838 | |
| 0.015 | 0.07 | 0.051 | Sodium/glucose cotransporter inhibitor | 0.051 0.005 CID_154699838 | CID_154699838 | |
| 0.046 | 0.101 | 0.062 | Lipocortins synthesis agonist | 0.062 0.032 CID_154699838 | CID_154699838 | |
| 0.047 | 0.104 | 0.111 | Topoisomerase II alpha inhibitor | 0.111 0.034 CID_154699838 | CID_154699838 | |
| 0.116 | 0.178 | 0.269 | Non-steroidal antiinflammatory agent | 0.269 0.036 CID_154699838 | CID_154699838 | |
| 0.062 | 0.129 | 0.085 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.085 0.073 CID_154699838 | CID_154699838 | |
| 0.227 | 0.295 | 0.695 | Antiinflammatory | 0.695 0.032 CID_154699838 | CID_154699838 | |
| 0.097 | 0.166 | 0.234 | Insulin secretagoues | 0.234 0.023 CID_154699838 | CID_154699838 | |
| 0.033 | 0.115 | 0.069 | Nitric oxide donor | 0.069 0.035 CID_154699838 | CID_154699838 | |
| 0.067 | 0.15 | 0.148 | Beta glucuronidase inhibitor | 0.148 0.026 CID_154699838 | CID_154699838 | |
| 0.123 | 0.211 | 0.212 | Cyclic AMP phosphodiesterase inhibitor | 0.212 0.085 CID_154699838 | CID_154699838 | |
| 0.023 | 0.119 | 0.092 | Protein 50S ribosomal subunit inhibitor | 0.092 0.015 CID_154699838 | CID_154699838 | |
| 0.079 | 0.187 | 0.246 | Anticoagulant | 0.246 0.039 CID_154699838 | CID_154699838 | |
| 0.057 | 0.17 | 0.1 | Thioredoxin inhibitor | 0.1 0.048 CID_154699838 | CID_154699838 | |
| 0.029 | 0.145 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.073 0.014 CID_154699838 | CID_154699838 | |
| 0.085 | 0.207 | 0.164 | DNA repair enzyme inhibitor | 0.164 0.021 CID_154699838 | CID_154699838 | |
| 0.063 | 0.19 | 0.094 | Phosphodiesterase 6D inhibitor | 0.094 0.066 CID_154699838 | CID_154699838 | |
| 0.047 | 0.181 | 0.157 | Topoisomerase II inhibitor | 0.157 0.046 CID_154699838 | CID_154699838 | |
| 0.072 | 0.222 | 0.168 | Diuretic | 0.168 0.063 CID_154699838 | CID_154699838 | |
| 0.059 | 0.214 | 0.09 | Interleukin 12 antagonist | 0.09 0.072 CID_154699838 | CID_154699838 | |
| 0.035 | 0.2 | 0.148 | Topoisomerase I inhibitor | 0.148 0.042 CID_154699838 | CID_154699838 | |
| 0.047 | 0.229 | 0.153 | AMP-activated protein kinase stimulant | 0.153 0.026 CID_154699838 | CID_154699838 | |
| 0.072 | 0.279 | 0.138 | DNA methylase inhibitor | 0.138 0.129 CID_154699838 | CID_154699838 | |
| 0.072 | 0.289 | 0.26 | Platelet antagonist | 0.26 0.068 CID_154699838 | CID_154699838 | |
| 0.068 | 0.291 | 0.192 | NOS3 expression enhancer | 0.192 0.044 CID_154699838 | CID_154699838 | |
| 0.019 | 0.317 | 0.068 | Heparanase inhibitor | 0.068 0.013 CID_154699838 | CID_154699838 | |
| 0.053 | 0.36 | 0.13 | Hexokinase inhibitor | 0.13 0.104 CID_154699838 | CID_154699838 | |
| 0.045 | 0.377 | 0.079 | T cell inhibitor | 0.079 0.068 CID_154699838 | CID_154699838 | |
| 0.08 | 0.433 | 0.361 | Immunomodulator | 0.361 0.056 CID_154699838 | CID_154699838 | |
| 0.012 | 0.388 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.016 CID_154699838 | CID_154699838 | |
| 0.084 | 0.484 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.07 CID_154699838 | CID_154699838 | |
| 0.039 | 0.483 | 0.292 | Tumour necrosis factor alpha release inhibitor | 0.292 0.056 CID_154699838 | CID_154699838 | |
| 0.019 | 0.619 | 0.156 | Cell adhesion inhibitor | 0.156 0.043 CID_154699838 | CID_154699838 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |